INTERNATIONAL PATENT: BGI GENOMICS CO., LTD., 深圳华大基因股份有限公司, SHIJIAZHUANG BGI CLINICAL LABORATORY CO., LTD., 石家庄华大医学检验实验室有限公司 FILES APPLICATION FOR "GENE MARKER COMBINATION AND USE THEREOF IN EARLY-ONSET PREECLAMPSIA RISK PREDICTION MODEL"

Posted On: 2025-05-16

GENEVA, May 16 -- BGI GENOMICS CO., LTD. (Floors 7-14, Building No. 7, BGI Park, No. 21 Hongan 3rd Street, Yantian DistrictShenzhen, Guangdong 518083), 深圳华大基因股份有限公司 (中国广东省深圳市盐田区洪安三街21号华大综合园7栋7层-14层), SHIJIAZHUANG BGI CLINICAL LABORATORY CO., LTD. (Building 4, ZhiTong Medicine Valley, No. 197 Taihang South Street, High-tech ZoneShijiazhuang, Hebei 050035), 石家庄华大医学检验实验室有限公司 (中&#...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: BGI GENOMICS CO., LTD., 深圳华大基因股份有限公司, SHIJIAZHUANG BGI CLINICAL LABORATORY CO., LTD., 石家庄华大医学检验实验室有限公司 FILES APPLICATION FOR "GENE MARKER COMBINATION AND USE THEREOF IN EARLY-ONSET PREECLAMPSIA RISK PREDICTION MODEL"